Literature DB >> 11876741

Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1-dominated cytokine response.

C Moser1, P O Jensen, O Kobayashi, H P Hougen, Z Song, J Rygaard, A Kharazmi, N H by.   

Abstract

Repeated challenge with antigen is involved in the pathogenesis of a variety of pulmonary diseases. Patients with cystic fibrosis (CF) experience recurrent pulmonary colonization with Pseudomonas aeruginosa before establishment of chronic lung infection. To mimic recurrent lung infections in CF patients, the lungs of susceptible BALB/c mice were re-infected with P. aeruginosa 14 days after the initial infection. Singly-infected BALB/c mice, as well as non-infected mice, were used as controls. Decreased mortality and milder lung inflammation in re-infected BALB/c mice, as well as a tendency for improved clearance of bacteria, was observed when compared with singly-infected mice. The improved outcome in re-infected mice correlated with changes in CD4 cell numbers. Surface expression of LFA-1 on pulmonary CD4 cells was increased in re-infected compared with singly-infected mice. Moreover, resistance to re-infection was paralleled by a shift towards a Th1-dominated response and increased IL-12 production. No significant increase in serum IgG was observed in the re-infected mice. In conclusion, these results indicate a protective role for a Th1-dominated response, independent of antibody production, in chronic P. aeruginosa lung infection in CF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11876741      PMCID: PMC1906339          DOI: 10.1046/j.1365-2249.2002.01731.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  47 in total

1.  The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type.

Authors:  C Moser; S Kjaergaard; T Pressler; A Kharazmi; C Koch; N Høiby
Journal:  APMIS       Date:  2000-05       Impact factor: 3.205

2.  Cytokine expression in bronchial biopsies of cystic fibrosis patients with and without acute exacerbation.

Authors:  C Wojnarowski; T Frischer; E Hofbauer; C Grabner; W Mosgoeller; I Eichler; R Ziesche
Journal:  Eur Respir J       Date:  1999-11       Impact factor: 16.671

3.  LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production.

Authors:  B Salomon; J A Bluestone
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

4.  Early immune response in susceptible and resistant mice strains with chronic Pseudomonas aeruginosa lung infection determines the type of T-helper cell response.

Authors:  C Moser; H P Hougen; Z Song; J Rygaard; A Kharazmi; N Høiby
Journal:  APMIS       Date:  1999-12       Impact factor: 3.205

5.  Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung.

Authors:  Kalai Mathee; Oana Ciofu; Claus Sternberg; Peter W Lindum; Joan I A Campbell; Per Jensen; Anders H Johnsen; Michael Givskov; Dennis E Ohman; Molin Søren; Niels Høiby; Arsalan Kharazmi
Journal:  Microbiology       Date:  1999-06       Impact factor: 2.777

6.  Repeated intratracheal challenge with particulate antigen modulates murine lung cytokines.

Authors:  J Todt; J Sonstein; T Polak; G D Seitzman; B Hu; J L Curtis
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

7.  Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate.

Authors:  C Filip; G Fletcher; J L Wulff; C F Earhart
Journal:  J Bacteriol       Date:  1973-09       Impact factor: 3.490

8.  Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis.

Authors:  N Hoiby; E W Flensborg; B Beck; B Friis; S V Jacobsen; L Jacobsen
Journal:  Scand J Respir Dis       Date:  1977-04

9.  Exposure of mice to live Pseudomonas aeruginosa generates protective cell-mediated immunity in the absence of an antibody response.

Authors:  R B Markham; W G Powderly
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

Review 10.  Localization of Th-cell subsets in inflammation: differential thresholds for extravasation of Th1 and Th2 cells.

Authors:  D D'Ambrosio; A Iellem; L Colantonio; B Clissi; R Pardi; F Sinigaglia
Journal:  Immunol Today       Date:  2000-04
View more
  35 in total

1.  Immunological considerations in the development of Pseudomonas aeruginosa vaccines.

Authors:  Sarah M Baker; James B McLachlan; Lisa A Morici
Journal:  Hum Vaccin Immunother       Date:  2019-09-05       Impact factor: 3.452

2.  Multiantigenic Nanotoxoids for Antivirulence Vaccination against Antibiotic-Resistant Gram-Negative Bacteria.

Authors:  Xiaoli Wei; Danni Ran; Anaamika Campeau; Crystal Xiao; Jiarong Zhou; Diana Dehaini; Yao Jiang; Ashley V Kroll; Qiangzhe Zhang; Weiwei Gao; David J Gonzalez; Ronnie H Fang; Liangfang Zhang
Journal:  Nano Lett       Date:  2019-06-11       Impact factor: 11.189

Review 3.  Chronic biofilm-based infections: skewing of the immune response.

Authors:  Juan F González; Mark M Hahn; John S Gunn
Journal:  Pathog Dis       Date:  2018-04-01       Impact factor: 3.166

4.  Cytokine signaling pathway in cystic fibrosis: expression of SOCS and STATs genes in different clinical phenotypes of the disease.

Authors:  Swati Sagwal; Rajendra Prasad; Jyotdeep Kaur; Meenu Singh
Journal:  Mol Cell Biochem       Date:  2021-03-19       Impact factor: 3.396

5.  Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis.

Authors:  Nadine Hoffmann; Thomas Bovbjerg Rasmussen; Peter Østrup Jensen; Charlotte Stub; Morten Hentzer; Søren Molin; Oana Ciofu; Michael Givskov; Helle Krogh Johansen; Niels Høiby
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

6.  Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa.

Authors:  Heinz Arnold; Dirk Bumann; Melanie Felies; Britta Gewecke; Meike Sörensen; J Engelbert Gessner; Joachim Freihorst; Bernd Ulrich von Specht; Ulrich Baumann
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

7.  Bead-size directed distribution of Pseudomonas aeruginosa results in distinct inflammatory response in a mouse model of chronic lung infection.

Authors:  L J Christophersen; H Trøstrup; D S Malling Damlund; T Bjarnsholt; K Thomsen; P Ø Jensen; H P Hougen; N Høiby; C Moser
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

8.  Faster activation of polymorphonuclear neutrophils in resistant mice during early innate response to Pseudomonas aeruginosa lung infection.

Authors:  P Ø Jensen; C Moser; O Kobayashi; H P Hougen; A Kharazmi; N Høiby
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

9.  Azithromycin increases survival and reduces lung inflammation in cystic fibrosis mice.

Authors:  Wan C Tsai; Marc B Hershenson; Ying Zhou; Umadevi Sajjan
Journal:  Inflamm Res       Date:  2009-03-07       Impact factor: 4.575

10.  Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host-pathogen interactions in cystic fibrosis.

Authors:  Claus Moser; Maria Van Gennip; Thomas Bjarnsholt; Peter Østrup Jensen; Baoleri Lee; Hans Petter Hougen; Henrik Calum; Oana Ciofu; Michael Givskov; Søren Molin; Niels Høiby
Journal:  APMIS       Date:  2009-02       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.